Market Indices
Latest News
 |
from Needham issued a price target of $7.00 for June 17, 2026 TOI 4.02% |
| ||
| ||
| ||
|
Price Targets
Eric Hagen from BTIG issued a price target of $9.00 for MITT on 2026-06-17 10:10:22.The adjusted price target was set to $9.00.At the time of the announcement, MITT...
June 17, 2026 MITT 1.39%
from Barrington issued a price target of $6.50 for LFCR on 2026-06-16 11:32:57.The adjusted price target was set to $6.50.At the time of the announcement, LFCR was...
June 16, 2026 LFCR 3.18%
Debjit Chattopadhyay from Guggenheim issued a price target of $123.00 for SPRB on 2026-06-16 10:40:22.The adjusted price target was set to $123.00.At the time of the announcement, SPRB...
June 16, 2026 SPRB 8.51%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| ICCM IceCure Medical Ltd | 7.73
262.91% | ||||||||||||||||||
| FTHM Fathom Holdings Inc. | 1.19
88.04% | ||||||||||||||||||
| ALOT AstroNova, Inc. | 28.41
70.22% | ||||||||||||||||||
| CLPT ClearPoint Neuro, Inc. | 18.17
36.18% | ||||||||||||||||||
| VRM Vroom, Inc. | 10.72
36.04% | ||||||||||||||||||
| ELTX Elicio Therapeutics, Inc. | 3.55
28.62% | ||||||||||||||||||
| GDHG Golden Heaven Group Holdi | 2.05
27.81% | ||||||||||||||||||
| CARM Carisma Therapeutics, Inc | 0.03
26.76% | ||||||||||||||||||
Annual/Quarterly Reports Summary
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
November 6, 2024 AIP 1.86%
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
November 6, 2024 EOSEW -34.96%
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
November 6, 2024 EOSE 16.44%
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
November 5, 2024 STOK 4.73%
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...
November 5, 2024 BSVN -0.85%